Status:
RECRUITING
Chronic Intestinal Pathologies Analytical Cohort at TouLouse
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Inflammatory Bowel Diseases
Colon Cancer
Eligibility:
All Genders
18-99 years
Brief Summary
In the general population, the percentage of people with at least one digestive disease is 16.7%. Among these digestive diseases, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and p...
Detailed Description
In the general population, the percentage of people with at least one digestive disease is 16.7%. Among these digestive diseases, two of them namely inflammatory bowel disease (IBD) and irritable bowe...
Eligibility Criteria
Inclusion
- Patient requiring endoscopic explorations for screening or follow-up in the context of a suspected IBS or IBD or colorectal cancer Or
- Patient with IBD requiring surgical management
- Patient over 18 years old
- Patient able to read and understand the information leaflet
- Patients who have given their consent to participate in the study
- Patients affiliated to a social security system (including AME)
Exclusion
- Patients who have received antibiotic treatments in the 10 days preceding endoscopic exploration
- Pregnant or breastfeeding patients
- Patients under 18 years old
- Patients under guardianship or curatorship
- Patients unable to sign a free and informed consent
Key Trial Info
Start Date :
April 29 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04896684
Start Date
April 29 2021
End Date
September 1 2025
Last Update
June 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rangueil University Hospital
Toulouse, France, 31059